- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Lonny Reisman: It's Time to Take Advantage of Big Data in Healthcare
Incorporating big data is essential as it can help explain failures in medical practice, accumulate patient information, and perform a variety of other useful functions, explained Lonny Reisman, MD, CEO of HealthReveal.
Incorporating big data is essential as it can help explain failures in medical practice, accumulate patient information, and perform a variety of other useful functions, explained Lonny Reisman, MD, CEO of HealthReveal.
Transcript (slightly modified)
With a number of challenges still facing big data, why is now the right time for it?
I think people understand that we need to do a better job with regards to quality and clinical excellence so, to the extent that there are frequent deviations in practice relative to the best standards, we can use big data to understand the basis for those failures. The second, I think, is the somewhat obvious notion that if there are all sorts of information available regarding how patients do vis-à-vis these outcomes relative to certain interventions, in addition to that they have the potential for toxicity for certain products post launch. The ability to aggregate and correlate all that information in ways that will inform practitioners and patients has got to be beneficial. And we’ve seen the use of big data in so many other aspects of our lives—banking, government activities, the fact that we haven’t fully taken advantage of it, or nearly taken advantage of it in healthcare I think is regrettable, but the time is now.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
